Document text
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Photos
#Preview
1.
2.
Date of Birth
1.DASZAK, PETERPlace of Birth
1.Place of Birth:DUKINFIELD
UNITED KINGDOM GB/GBR
City:DUKINFIELD
Country:United Kingdom (GB/GBR)
2.Country:United Kingdom (GB/GBR)
Citizenship
United States (US/USA)
Disposition
1.Disposition Category:
Disposition: ActionUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Disposition Reason
1.Remarks:Referred to . FBI requested not to stop subject. No further
NTC action
Records
#Person Record Name S
ubtype Record ID Code
1.
2.PNR
3.PNR
4.TECS
Conveyances
1.MOT:Air-Commercial
Est Departure:01/12/2021 01:00:00 EST
Est Arrival:01/12/2021 13:15:00 EST
Flight No:704
Carrier:QATAR AIRWAYS (QR)
F
rom Port:John F Kennedy International Airport (JFK)
To Port:Hamad International Airport (DOH)
Itinerary Description: John F Kennedy International Airport(JFK)-Hamad International Airport(DOH)
2.MOT:Air-Commercial
Est Departure:02/04/2021 13:00:00 EST
Est Arrival:02/04/2021 21:30:00 EST
Flight No:945UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Carrier:QATAR AIRWAYS (QR)
From Port:Singapore Changi Airport (SIN)
To Port:Hamad International Airport (DOH)
Itinerary
Description:Singapore Changi Airport(SIN)-Hamad International Airport(DOH); Hamad
International Airport(DOH)-Singapore Changi Airport(SIN); Hamad
International Airport(DOH)-John F Kennedy International Airport(JFK)
3.MOT:Air-Commercial
Est Departure:01/12/2021 18:10:00 EST
Est Arrival:01/13/2021 01:55:00 EST
Flight No:946
Carrier:QATAR AIRWAYS (QR)
F
rom Port:Hamad International Airport (DOH)
To Port:Singapore Changi Airport (SIN)
Itinerary
Description:Singapore Changi Airport(SIN)-Hamad International Airport(DOH); Hamad
International Airport(DOH)-Singapore Changi Airport(SIN); Hamad
International Airport(DOH)-John F Kennedy International Airport(JFK)
4.MOT:Air-Commercial
Est Departure:02/05/2021 00:15:00 EST
Est Arrival:02/05/2021 14:25:00 EST
Flight No:701
Carrier:QATAR AIRWAYS (QR)
F
rom Port:Hamad International Airport (DOH)
To Port:John F Kennedy International Airport (JFK)
Itinerary
Description:Singapore Changi Airport(SIN)-Hamad International Airport(DOH); Hamad
International Airport(DOH)-Singapore Changi Airport(SIN); Hamad
International Airport(DOH)-John F Kennedy International Airport(JFK)
5.MOT:Air-Commercial
Est Departure:01/04/2021 21:00:00 EST
Est Arrival:01/05/2021 09:15:00 EST
Flight No:QR 702
Carrier:QATAR AIRWAYS (QR)
F
rom Port:John F Kennedy International Airport (JFK)
To Port:Hamad International Airport (DOH)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
6.MOT:Air-Commercial
Est Departure:01/05/2021 12:30:00 EST
Est Arrival:12/31/1969 20:45:00 EST
Flight No:QR 942
Carrier:QATAR AIRWAYS (QR)
F
rom Port:Hamad International Airport (DOH)
To Port:Singapore Changi Airport (SIN)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
7.MOT:Air-Commercial
Est Departure:02/04/2021 21:00:00 EST
Est Arrival:01/01/1970 11:35:00 ESTUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Flight No:UA 2
Carrier:UNITED AIRLINES (UA)
From Port:Singapore Changi Airport (SIN)
To Port:San Francisco International Airport (SFO)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
8.MOT:Air-Commercial
Est Departure:02/05/2021 13:45:00 EST
Est Arrival:01/01/1970 19:23:00 EST
Flight No:UA 1900
Carrier:UNITED AIRLINES (UA)
F
rom Port:San Francisco International Airport (SFO)
To Port:Newark Liberty International Airport (EWR)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
Activity Reason
GLOBAL TACTICAL OPERATIONS BRANCHUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Activity Remarks
Re
m
ar
k
Ty
peRemark
RE
MA
RK* DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for
genetic analysis, and return it to the United States. He was also asked to explain several
aspects of their collaboration, including related to cell phone data. DASZAK called the
requirements "outrageous" and does not appear to intend to comply with them
(https://www.sciencemag.org/news/2020/08/nih-imposes-outrageous-conditions-resuming-coronavirus-
grant-targeted-trump)
* DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S.
federal government. These include contracts with the DHS Chemical and Biological Threat
Division. Many items that EcoHealth studies are likely to be subject to serious non-disclosure
agreements with the U.S. government and/or be export controlled.
More background information in the kind of research that DASZAK is heavily involved in. A lot of
the funding DASZAK receives is put towards "gain of function research" also known as biological
weapons research. This research involves experimentation that aims or is expected to increase
the transmissibility and/or virulence of pathogens. Such research, when conducted by responsible
scientists, usually aims to improve understanding of disease causing agents, their interaction
with human hosts, and/or their potential to cause pandemics. The ultimate objective of such
research is to better inform public health and preparedness efforts and/or development of medical
countermeasures. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996883/ In gain of function
research, genome sequences are reconstructed/reformulated and are inserted into human/animal
cells to be studied on how the "new" sequence effects humans and/or animals. There is a lot of
criticism on gain of function research in regards to ethics and if the science is worth the risks
of creating a potentially harmful virus or disease.
In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat SARS-like
coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper is of
significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1) binding to
human cells and infecting them. https://www.nature.com/articles/nature12711#Sec2 Essentially,
DASZAK and collaborators at WIV created a bat coronavirus capable of directly infecting humans.
A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat virus stirs
debate over risky research, Lab-made coronavirus related to SARS can infect human cells" debates
"whether engineering lab variants of viruses with possible pandemic potential is worth the
risks." https://www.nature.com/news/engineered-bat-virus-stirs-debate-over-risky-research-
%201.18787
During the inspection, it is hard to say if DASZAK will be forthcoming with information.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RKFrom: CBP.DHS.GOV>
Sent: Tuesday, February 2, 2021 10:18 PM
To: cbp.dhs.gov>
Cc: REFERRALS cbp.dhs.gov>; S
@cbp.dhs.gov>
Subject: Re: Subject Event 3 P. DASZAK C
10-4, thanks. We'll send it out in the morning.
Charlie
Sent from my iPhone
On Feb 2, 2021, at 10:11 PM, cbp.dhs.gov> wrote:
Good evening ,
***FYSA - NTC has rescinded previous inspection request; however, subject may be of interest to
the FBI ***
Peter DASZAK (DOB: is scheduled to travel from DOH to JFK on
02/05/2021, aboard QR #701 ETA 1425 EST- Event has been created for additional
information.
*** Reference event for notable publications and news articles.***
Background
Peter DASZAK (DOB: is the President of EcoHealth
Alliance; a US science-based non-profit that conducts research and outreach on the causes of
emerging pandemic diseases, and their links to environmental change and conservation (Link).
DASZAK's scientific research is focused on understanding the drivers of emerging diseases to
include: evidence that emerging disease, chytridiomycosis, causes global amphibian declines; the
first ever map of emerging disease 'hotspots'; and the identification of bats as a reservoir for
SARS. DASZAK's goals are to understand what drives disease emergence develop innovative ways to
stop emerging diseases in wildlife, livestock and people; and promote conservation of wildlife.
DASZAK, is part of the World Health Organization (WHO) team that is investigating the origins of
SARS-CoV-2, the virus that causes COVID-19 (Link). DASZAK is also affiliated with Zhengli SHI
(Bat Woman) - the lead Virologist and Researcher at the Wuhan Institute of Virology (WIV),
Chinese Academy of Sciences (CAS) Link. SHI's areas of study include: Bats, Viral Ecology, Viral
Entry, Virus Discovery, Zoonotic Diseases, Virology, Ecology of Pathogens (Link). EcoHealth
Alliance and DASZAK have been working with Shi Zhengli for more than 15 years.
DASZAK is listed as the Principal Investigator (PI) on National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID) grants: 1U01AI151797-01 -
Understanding Risk of Zoonotic Viruses Emergence in EID Hotspots of Southeast Asia, and
#2R01AI110964-06: Understanding the Risk of Bat Coronavirus Emergence, dated 6/01/2014-
06/30/2024. SHI listed grant R01AI110964 on her resume (Link), although SHI is not listed as a
PI. A search of the grant revealed 19 publications (Link), many of which were written by SHI.
Additional information
* DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for
genetic analysis, and return it to the United States. He was also asked to explain several UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemarkaspects of their collaboration, including related to cell phone data. Link
* DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S.
federal government. These include contracts with the DHS Chemical and Biological Threat Division.
Many items that EcoHealth studies are likely to be subject to serious non-disclosure agreements
with the U.S. government and/or be export controlled.
* Much of the funding DASZAK receives is put towards gain of function research. This
research involves experimentation that aims or is expected to increase the transmissibility
and/or virulence of pathogens. The ultimate objective of such research is to better inform public
health and preparedness efforts and/or development of medical countermeasures. Link
* In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat
SARS-like coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper
is of significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1)
binding to human cells and infecting them. Link
* A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat
virus stirs debate over risky research, Lab-made coronavirus related to SARS can infect human
cells" debates "whether engineering lab variants of viruses with possible pandemic potential is
worth the risks." Link
Respectfully,
National Targeting Security Specialist
National Targeting Center (NTC)
Tactical Targeting
WARNING: This document is LAW ENFORCEMENT SENSITIVE and is designated for OFFICIAL USE ONLY. It
contains information that may be exempt from public release under the Freedom of Information Act
(5USC552). This document is to be controlled, handled, transmitted, distributed, and disposed of
in accordance with DHS policy relating to FOUO information, and is not to be released to the
public or personnel who do not have a valid "need-to-know" without prior approval from OFO
National Targeting Center - Passenger at 571-468-1000.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RKFrom: cbp.dhs.gov>
Sent: Tuesday, February 2, 2021 8:55 PM
To: cbp.dhs.gov>; J bp.dhs.gov>; NY
REFERRALS cbp.dhs.gov>
Cc: NTC-P cbp.dhs.gov>; P
@cbp.dhs.gov>
Subject: RE: Referral Event 3 P. DASZAK C
10/4
Supervisory Officer- TTRT
US Customs and Border Protection
From: cbp.dhs.gov>
Sent: Tuesday, February 2, 2021 8:49 PM
To: cbp.dhs.gov>; N REFERRALS < bp.dhs.gov>
Cc: NTC-P NatSec Group cbp.dhs.gov>; P
@cbp.dhs.gov>
Subject: Referral Event 3 P. DASZAK C
Good afternoon,
Please consider the following subject for a TTRT Exam.
Peter DASZAK (DOB: is scheduled to travel from DOH to JFK on
02/05/2021, aboard QR #701 ETA 1425 EST- Event has been created for additional
information.
*** Reference event for notable publications and news articles.***
Background
Peter DASZAK (DOB: is the President of EcoHealth
Alliance; a US science-based non-profit that conducts research and outreach on the causes of
emerging pandemic diseases, and their links to environmental change and conservation (Link).
DASZAK's scientific research is focused on understanding the drivers of emerging diseases to
include: evidence that emerging disease, chytridiomycosis, causes global amphibian declines; the
first ever map of emerging disease 'hotspots'; and the identification of bats as a reservoir for
SARS. DASZAK's goals are to understand what drives disease emergence develop innovative ways to
stop emerging diseases in wildlife, livestock and people; and promote conservation of wildlife.
DASZAK, is part of the World Health Organization (WHO) team that is investigating the origins of
SARS-CoV-2, the virus that causes COVID-19 (Link). DASZAK is also affiliated with Zhengli SHI
(Bat Woman) - the lead Virologist and Researcher at the Wuhan Institute of Virology (WIV),
Chinese Academy of Sciences (CAS) Link. SHI's areas of study include: Bats, Viral Ecology, Viral
Entry, Virus Discovery, Zoonotic Diseases, Virology, Ecology of Pathogens (Link). EcoHealth
Alliance and DASZAK have been working with Shi Zhengli for more than 15 years.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
DASZAK is listed as the Principal Investigator (PI) on National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID) grants: 1U01AI151797-01 -
Understanding Risk of Zoonotic Viruses Emergence in EID Hotspots of Southeast Asia, and
#2R01AI110964-06: Understanding the Risk of Bat Coronavirus Emergence, dated 6/01/2014-
06/30/2024. SHI listed grant R01AI110964 on her resume (Link), although SHI is not listed as a
PI. A search of the grant revealed 19 publications (Link), many of which were written by SHI.
Additional information
* DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for
genetic analysis, and return it to the United States. He was also asked to explain several
aspects of their collaboration, including related to cell phone data. Link
* DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S.
federal government. These include contracts with the DHS Chemical and Biological Threat Division.
Many items that EcoHealth studies are likely to be subject to serious non-disclosure agreements
with the U.S. government and/or be export controlled.
* Much of the funding DASZAK receives is put towards gain of function research. This
research involves experimentation that aims or is expected to increase the transmissibility
and/or virulence of pathogens. The ultimate objective of such research is to better inform public
health and preparedness efforts and/or development of medical countermeasures. Link
* In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat
SARS-like coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper
is of significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1)
binding to human cells and infecting them. Link
* A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat
virus stirs debate over risky research, Lab-made coronavirus related to SARS can infect human
cells" debates "whether engineering lab variants of viruses with possible pandemic potential is
worth the risks." Link
NTC Requests
* TTRT exam to include review of media (search level determined by POE).
* Why was DASZAK chosen to be on the WHO investigative team?
* Where in China did DASZAK go?
* Where did DASZAK stay while in China?
* Who was the POC?
* Did the team visit WIV? If so, what areas did they inspect? Who did the team meet with?
* Did the team visit the Chinese Center for Disease Control and Prevention? If so, what
areas did they inspect? Who did the team meet with?
* Did the team meet with any other officials from the Chinese government?
* Did DASZAK collect any biological samples during the trip?
* Is DASZAK traveling with any biological samples?
* Did he mail any samples back to the US?
* Did he take any materials with him to China?
* Has DASZAK maintained contact with anyone at the WIV? If so, whom and how often would he
communicate? What do they communicate about?
* What was the purpose of DASZAK's travel from 01/04/2021-01/07/2021?
Respectfully,
National Targeting Security Specialist
National Targeting Center (NTC)UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemarkTactical Targeting
UNCLASS:
HSDN:
JWICS:
Phone:
WARNING: This document is LAW ENFORCEMENT SENSITIVE and is designated for OFFICIAL USE ONLY. It
contains information that may be exempt from public release under the Freedom of Information Act
(5USC552). This document is to be controlled, handled, transmitted, distributed, and disposed of
in accordance with DHS policy relating to FOUO information, and is not to be released to the
public or personnel who do not have a valid "need-to-know" without prior approval from OFO
National Targeting Center - Passenger at 571-468-1000.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RKHey ,
Do you have additional information besides this?
Peter DASZAK
* President of EcoHealth Alliance - US based non-profit organization that conducts research
and outreach programs on global health, conservation and international development//collaborates
with scientists around the world to discover new viruses in wildlife
https://www.scientificamerican.com/article/how-chinas-bat-woman-hunted-down-viruses-from-sars-to-
the-new-coronavirus1/ // https://www.ecohealthalliance.org/
* Listed as the Principle Investigator on National Institute of Health (NIH) National
Institute of Allergy and Infectious Diseases (NIAID) grant #2R01AI110964-06 "Understanding the
Risk of Bat Coronavirus Emergence" data indicates project dates 06/01/2014-06/30/2024 (Shi listed
this grant on her resume and is not a PI)
*
A search this grant revealed 19 publications https://www.ncbi.nlm.nih.gov/pubmed?
term=R01+AI110964/AI/NIAID+NIH+HHS/United+States[Grant+Number]
o Articles of interest
* Origin and evolution of pathogenic coronaviruses Nature Reviews Microbiology volume 17,
pages181-192(2019) Authors - Jie Cui, Fang Li & Zheng-Li Shi This work was jointly funded by the
Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29010000), the
National Natural Science Foundation of China (31621061) and the US National Institutes of Health
(NIH) National Institute of Allergy and Infection Diseases (R01AI110964) to Z.-L.S; NIH grants
(R01AI089728 and R01AI110700) to F.L.; the CAS Pioneer Hundred Talents Program to J.C.; and the
Wuhan Institute of Virology (WIV) "One-Three-Five" Strategic Program (WIV-135-TP1) to J.C. and
Z.-L.S
* Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle
East Respiratory Syndrome Coronavirus Journal of Virology Jun 2018, 92 (13) e00116-18 Authors -
Chu-Ming Luo, Ning Wang, Xing-Lou Yang, Hai-Zhou Liu, Wei Zhang, Bei Li, Ben Hu, Cheng Peng, Qi-
Bin Geng, Guang-Jian Zhu, Fang Li, Zheng-Li Shi This study was jointly funded by the Scientific
and Technological Basis Special Project (2013FY113500) from the Ministry of Science and
Technology of the People's Republic of China to Z.-L.S., a USAID Emerging Pandemic Threats
PREDICT project grant (Cooperative Agreement no. AID-OAA-A-14-00102), NIH grants (R01AI110964 to
Z.-L.S.; R01AI089728 and R01AI110700 to F.L.), and the National Natural Science Foundation of
China (31727901) to Z.-L.S.
* Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like
coronaviruses Science China Life Sciences volume 60, pages 1399-1402 (2017) Authors -Lei-Ping
Zeng, Xing-Yi Ge, Cheng Peng, Wanbo Tai, Shibo Jiang, Lanying Du & Zheng-Li Shi In the
acknowledge section "This work was supported by the National Natural Science Foundation of China
(81290341, 31621061 to Zheng-Li Shi), the Strategic Priority Research Program of the Chinese
Academy of Sciences (XDPB0301 to Zheng-Li Shi), National Institute of Allergy and Infectious
Diseases of National Institutes of Health grant (R01AI110964 to Zheng-Li Shi), the National Key
Research and Development Program of China (2016YFC1201000 to Shibo Jiang) and NIH grant
(R01AI098775 to Shibo Jiang and Lanying Du)"
* Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights
into the origin of SARS coronavirus PLoS Pathog. 2017 Nov; 13(11): e1006698 Authors - Ben Hu,
Lei-Ping Zeng, Xing-Lou Yang, Xing-Yi Ge, Wei Zhang, Bei Li, Jia-Zheng Xie, Xu-Rui Shen, Yun-Zhi
Zhang, Ning Wang, Dong-Sheng Luo, Xiao-Shuang Zheng, Mei-Niang Wang, Peter Daszak, Lin-Fa Wang,
Jie Cui, Zheng-Li Shi
* Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China
Virologica Sinica volume 33, pages104-107(2018) Authors - Ning Wang, Shi-Yue Li, Xing-Lou Yang,
Hui-Min Huang, Yu-Ji Zhang, Hua Guo, Chu-Ming Luo, Maureen Miller, Guangjian Zhu, Aleksei A.
Chmura, Emily Hagan, Ji-Hua Zhou, Yun-Zhi Zhang, Lin-Fa Wang, Peter Daszak & Zheng-Li Shi This
study was jointly funded by the National Natural Science Foundation of China Grant (81290341) to
ZLS; the National Institute of Allergy and Infectious Diseases of the National Institutes of
Health (Award Number R01AI110964) to PD and ZLS, United States Agency for International
Development (USAID) Emerging Pandemic Threats PREDICT project Grant (Cooperative Agreement No. UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemarkUS Customs and Border ProtectionUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RK
[email protected]
Linkedin: https://www.linkedin.com/in/peter-daszak-93987665/
Eco Alliance: https://www.ecohealthalliance.org/
SHI Bio: https://www.ws-virology.org/dt_team/zhengli-shi/
SHI CV: https://www.ws-virology.org/wp-content/uploads/2017/11/Zhengli-Shi.pdf
Relevant News articles
https://www.scientificamerican.com/article/how-chinas-bat-woman-hunted-down-viruses-from-sars-to-
the-new-coronavirus1/
https://childrenshealthdefense.org/defender/conflicts-of-interest-taint-investigations-covid-
origins/
https://www.sciencemag.org/news/2020/08/nih-imposes-outrageous-conditions-resuming-coronavirus-
grant-targeted-trump
Gain of Function Research: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996883/
https://www.telegraph.co.uk/global-health/science-and-disease/exclusive-mission-really-big-step-
forward-understand-covid-19/
https://www.nature.com/news/engineered-bat-virus-stirs-debate-over-risky-research-%201.18787
https://www.scmp.com/news/china/science/article/3111314/who-names-line-international-team-
looking-coronavirus-origins
https://www.nature.com/articles/d41586-020-02473-4
https://www.pressreader.com/uk/the-mail-on-sunday/20210110/281831466368322
Articles of interest
* Origin and evolution of pathogenic coronaviruses Nature Reviews Microbiology volume 17,
pages181-192(2019) Authors - Jie Cui, Fang Li & Zheng-Li Shi This work was jointly funded by the
Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29010000), the
National Natural Science Foundation of China (31621061) and the US National Institutes of Health
(NIH) National Institute of Allergy and Infection Diseases (R01AI110964) to Z.-L.S; NIH grants
(R01AI089728 and R01AI110700) to F.L.; the CAS Pioneer Hundred Talents Program to J.C.; and the
Wuhan Institute of Virology (WIV) "One-Three-Five" Strategic Program (WIV-135-TP1) to J.C. and
Z.-L.S
*
Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle
East Respiratory Syndrome Coronavirus Journal of Virology Jun 2018, 92 (13) e00116-18 Authors -
Chu-Ming Luo, Ning Wang, Xing-Lou Yang, Hai-Zhou Liu, Wei Zhang, Bei Li, Ben Hu, Cheng Peng, Qi-
Bin Geng, Guang-Jian Zhu, Fang Li, Zheng-Li Shi This study was jointly funded by the Scientific
and Technological Basis Special Project (2013FY113500) from the Ministry of Science and
Technology of the People's Republic of China to Z.-L.S., a USAID Emerging Pandemic Threats
PREDICT project grant (Cooperative Agreement no. AID-OAA-A-14-00102), NIH grants (R01AI110964 to
Z.-L.S.; R01AI089728 and R01AI110700 to F.L.), and the National Natural Science Foundation of
China (31727901) to Z.-L.S.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Released by Chairman Rand Paul
UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul